Medivation, Inc.

Press Releases

Company News
View Summary Medivation Announces Second Quarter 2015 Financial Results Teleconference on August 6, 2015
Jul 16, 2015
PDF 9.0 KB Add to Briefcase
View Summary Medivation Voted Three Years in a Row Among Top Workplaces in the San Francisco Bay Area
Jun 29, 2015
PDF 9.7 KB Add to Briefcase
View Summary Medivation to Redeem Outstanding Convertible Notes Due 2017
Jun 19, 2015
PDF 9.5 KB Add to Briefcase
View Summary Medivation and Astellas Announce Enrollment of the First Patients in Advanced Prostate Cancer Outcomes Registry
Jun 17, 2015
PDF 13.3 KB Add to Briefcase
View Summary New Enzalutamide Data in Triple-Negative Breast Cancer Presented at the 2015 American Society of Clinical Oncology Annual Meeting
Jun 1, 2015
PDF 163.0 KB Add to Briefcase
View Summary Medivation Names Andrew Powell General Counsel
May 28, 2015
PDF 10.3 KB Add to Briefcase
View Summary Medivation and Astellas Announce New Enzalutamide Data Presented at the 2015 American Urology Association Annual Meeting
May 17, 2015
PDF 157.9 KB Add to Briefcase
View Summary New Enzalutamide Data in Triple-Negative Breast Cancer to Be Presented at the 2015 ASCO Annual Meeting
May 14, 2015
PDF 153.4 KB Add to Briefcase
View Summary Medivation Reports First Quarter 2015 Financial Results
May 7, 2015
PDF 181.1 KB Add to Briefcase
View Summary New Enzalutamide Data to Be Presented in Late Breaking Plenary Session at AUA Annual Meeting
May 5, 2015
PDF 155.6 KB Add to Briefcase
View Summary Medivation Announces Participation at Upcoming Investor Conference
May 4, 2015
PDF 9.1 KB Add to Briefcase
View Summary Medivation Announces First Quarter 2015 Financial Results Teleconference on May 7, 2015
Apr 23, 2015
PDF 9.1 KB Add to Briefcase
View Summary Enzalutamide Demonstrates Statistically Significant Improvement in Progression Free Survival Compared With Bicalutamide in Strive Trial
Apr 2, 2015
PDF 156.4 KB Add to Briefcase
View Summary Medivation and Astellas Announce New Enzalutamide Data Presented During Plenary Presentations at the 2015 European Association of Urology Congress
Mar 24, 2015
PDF 162.9 KB Add to Briefcase
View Summary New Enzalutamide Data to Be Presented in Late Breaking News Plenary Session at European Association of Urology Congress
Mar 16, 2015
PDF 156.2 KB Add to Briefcase
View Summary Medivation Reports Fourth Quarter and Full Year 2014 Financial Results and Provides Corporate Update
Feb 25, 2015
PDF 182.7 KB Add to Briefcase
View Summary Medivation Announces Participation at Upcoming Investor Conference
Feb 24, 2015
PDF 9.1 KB Add to Briefcase
View Summary Medivation Announces Fourth Quarter and Year-End 2014 Financial Results Teleconference on February 25, 2015
Feb 11, 2015
PDF 9.2 KB Add to Briefcase
View Summary Enzalutamide Phase 2 Terrain Trial Demonstrated Statistically Significant Increase in PFS as Compared to Bicalutamide in Metastatic Prostate Cancer
Jan 22, 2015
PDF 156.1 KB Add to Briefcase
View Summary Medivation Exercises License Option for Pidilizumab
Dec 22, 2014
PDF 9.9 KB Add to Briefcase
Showing 1-20 of 335 Page: 1 2 3 4 5 ... 17  Next 20
Add to Briefcase = add release to Briefcase